Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06333990
Status:
RECRUITING
Last Update Posted:
2024-03-27
First Post:
2024-03-20
Brief Title:
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury mTBI
Sponsor:
Foundation for Advancing Veterans Health Research
Organization:
Foundation for Advancing Veterans Health Research
Study Overview
Official Title:
A Randomized Clinical Trial of Quetiapine to Reduce Post Concussive Syndrome Polypharmacy
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A two site 2-arm Phase III randomized pragmatic clinical trial evaluating the effectiveness of quetiapine monotherapy in comparison to Treatment As Usual TAU medication management for symptoms experienced by veterans receiving rehabilitation therapy for mild traumatic brain injury mTBI and comorbid symptoms of posttraumatic stress disorder PTSD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None